2Indexed trials
drug · Product Intelligence
Natalizumab
Pipeline Intelligence
Natalizumab: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT02325440University Hospital Muenster · multiple_sclerosisPHASE4
NCT03283371Biogen · epilepsyPHASE2
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.